Making trials part of good clinical care: lessons from the RECOVERY trial
When COVID-19 hit the UK in early 2020, there were no known treatments for a condition that results in the death of around one in four patients hospitalised with this disease. Around the world, possible treatments were administered to huge numbers of patients, without any reliable assessments of saf...
Main Authors: | Pessoa-Amorim, G, Campbell, M, Fletcher, L, Horby, P, Landray, M, Mafham, M, Haynes, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Royal College of Physicians
2021
|
Similar Items
-
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Mafham, M, et al.
Published: (2021) -
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Landray, M, et al.
Published: (2022) -
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Horby, P, et al.
Published: (2024) -
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
by: Horby, PW, et al.
Published: (2023) -
In practice: RECOVERY Trial
by: Horby, P, et al.
Published: (2024)